相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities
Desislava Yanakieva et al.
MABS (2022)
Nano Differential Scanning Fluorimetry-Based Thermal Stability Screening and Optimal Buffer Selection for Immunoglobulin G
Soo Hyun Kim et al.
PHARMACEUTICALS (2022)
An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH
Yutong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Immobilization-Free Binding and Affinity Characterization of Higher Order Bispecific Antibody Complexes Using Size-Based Microfluidics
Andreas Madsen et al.
ANALYTICAL CHEMISTRY (2022)
Immobilization-Free Binding and Affinity Characterization of Higher Order Bispecific Antibody Complexes Using Size-Based Microfluidics
Andreas Madsen et al.
ANALYTICAL CHEMISTRY (2022)
Size-based characterization of adalimumab and TNF-α interactions using flow induced dispersion analysis: assessment of avidity-stabilized multiple bound species
Morten E. Pedersen et al.
SCIENTIFIC REPORTS (2021)
Expression liabilities in a four-chain bispecific molecule
Cai Guo et al.
BIOTECHNOLOGY AND BIOENGINEERING (2021)
Format and geometries matter: Structure-based design defines the functionality of bispecific antibodies
Steffen Dickopf et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices
Stefan Dengl et al.
NATURE COMMUNICATIONS (2020)
Molecular engineering strategies and methods for the expression and purification of IgG1-based bispecific bivalent antibodies
N. Dimasi et al.
METHODS (2019)
A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities
Yifeng Li
PROTEIN EXPRESSION AND PURIFICATION (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
Shuguang Tan et al.
PROTEIN & CELL (2018)
The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding
Wai-Heng Lua et al.
SCIENTIFIC REPORTS (2018)
Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts
Christoph Goletz et al.
FRONTIERS IN IMMUNOLOGY (2018)
Characterization and analysis of scFv-IgG bispecific antibody size variants
Mingyan Cao et al.
MABS (2018)
A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1
Camilla De Nardis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Biophysical properties of the clinical-stage antibody landscape
Tushar Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
Fei Zhang et al.
ONCOTARGET (2017)
Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity
Andrew D. Tustian et al.
MABS (2016)
A Trojan horse bispecific-antibody strategy for broad protection against ebolaviruses
Anna Z. Wec et al.
SCIENCE (2016)
Fab-based bispecific antibody formats with robust biophysical properties and biological activity
Xiufeng Wu et al.
MABS (2015)
Molecular weight-gyration radius relation of globular proteins: a comparison of light scattering, small-angle X-ray scattering and structure-based data
Detlef-M. Smilgies et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2015)
Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detection
Alexandra Lavoisier et al.
MABS (2015)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Mechanical Stability of the Antibody Domain CH3 Homodimer in Different Oxidation States
Morten Bertz et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
Zenjiro Sampei et al.
PLOS ONE (2013)
Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibition
Rebecca Croasdale et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
Charlotte F. McDonagh et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer
Ilse Vaneycken et al.
FASEB JOURNAL (2011)
A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
Gregory L. Moore et al.
MABS (2011)
Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects APPLICATIONS TO BISPECIFIC MOLECULES AND MONOVALENT IgG
Kannan Gunasekaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
How antibodies fold
Matthias J. Feige et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle et al.
CANCER RESEARCH (2009)
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
Jennifer S. Michaelson et al.
MABS (2009)
Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies
Roxana M. Ionescu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
Stability engineering of antibody single-chain Fv fragments
A Wörn et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)